Affinity DataIC50: 47nMAssay Description:Inhibition of human UGT2B7 by substrate-independent inhibition assayMore data for this Ligand-Target Pair
Affinity DataIC50: 54nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 700nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 700nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 800nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 800nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 900nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 900nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 900nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of UGT1A1 in rat liver microsomes using beta-estradiol as substrate preincubated for 5 mins followed by substrate addition and measured af...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 4.20E+3nMAssay Description:Inhibition of recombinant rat UGT1A1 using beta-estradiol as substrate preincubated for 5 mins followed by substrate addition and measured after 40 m...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of UGT2B7 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of UGT2B15 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 1.26E+4nMAssay Description:Inhibition of recombinant rat UGT1A1 using beta-estradiol as substrate preincubated for 5 mins followed by substrate addition and measured after 40 m...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of human UGT2B7 assessed as reduction of estriol glucuronidationMore data for this Ligand-Target Pair